Navigation Links
Lilly Reports First-Quarter 2013 Results
Date:4/24/2013

rcent, compared with 24.4 percent in the first quarter of 2012, primarily driven by the reinstatement of the R&D tax credit in the U.S. for the first quarter of 2013 as well as the one-time impact of the R&D tax credit for 2012 that was recorded in the first quarter of 2013. Net income and earnings per share were $1.248 billion and $1.14, respectively, compared with $1.027 billion and $0.92 during the first quarter of 2012.  These increases were driven by a lower tax rate, higher other income and higher operating income.

Non-GAAP results in the first quarter of 2013 exclude items totaling $0.28 of income. For the first quarter of 2012, expenses totaling $0.01 per share were excluded. For further detail, see the reconciliation below as well as the footnotes to the non-GAAP income statement later in this press release.First Quarter20132012

% ChangeEarnings per share (reported)$1.42$0.9156%Asset impairment, restructuring and other special charges

 

0.01 

0.01Income from the transfer of exenatide commercial rights

(0.29)-Earnings per share (non-GAAP)  $1.14$0.9224% 

 

Revenue Highlights 

(Dollars in millions)

 

First Quarter

% Change
Over/(Under)20132012

2012Cymbalta®

$1,328.2$1,114.919%Humalog®

632.7590.37%Alimta®

616.8606.82%Cialis

515.0461.811%Humulin®

311.9307.71%Zyprexa

284.8562.7(49)%Forteo®

281.5271.34%Evista®

240.6256.2(6)%Strattera®

166.7158.95%Effient®

115.9115.80%Animal Health

499.1490.72%Total Revenue

$5,602.0$5,602.00%Cymbalta
For the first quarter of 2013, Cymbalta generated $1.328 billion in revenue, an increase of 19 percent compared with the first quarter of 2012.
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Research and Markets ( ... "Global POC Diagnostics Market 2015-2019" report to their ... Global POC Diagnostics market to grow at a CAGR ... POC diagnostics are IVD devices and tools used ... setting. The use of these devices helps in the ...
(Date:3/3/2015)... 2015  Columbia Laboratories, Inc. (Nasdaq: CBRX ... a specialty pharmaceutical company focused on pharmaceuticals for women,s ... 27th Annual ROTH Conference, which will take place from ... Dana Point, California . Management,s presentation will ... Pacific Time (12:00 p.m. Eastern Time) in the Promenade ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research ... announced the addition of the "Global Ultrasound ... , The Global Ultrasound ... 5.79% over the period 2014-2019 Ultrasound ... sound waves. Ultrasound systems are extensively used by ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... and Safety of ,First Generation, Antisense, BERKELEY ... GNTA ) announced the presentation of new data ... can be safely administered in high doses by ... presented by Dr. Anthony Tolcher, Director,of Clinical Research, ...
... Improvement in Hemodynamics and Delay Disease Progression -, ... Inc.,today announced positive results from two trials demonstrating ... a combination therapy,for the treatment of pulmonary arterial ... when given in combination with sildenafil,is well-tolerated and ...
Cached Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 3, 2015) (PRWEB) March 03, 2015 ... an innovator in the travel industry for the past ... expansion plan. To fulfill his vision for the future ... 400 fun, exciting and well-compensated positions as travel sales ... news sales center planned for the Boynton Beach, Florida ...
(Date:3/3/2015)... Retrofit , the comprehensive weight ... corporations, today announces the appointment of its new chief ... Mary Pigatti has recruited technology, healthcare and ... for the fast-growing company, which was recently named one ... 2015. , “Retrofit is thrilled to announce this new ...
(Date:3/3/2015)... March 03, 2015 According to ... http://www.idataresearch.com ), market saturation has made neurosurgery navigation ... the United States. Unit sales growth moderately increased ... as facilities replace older systems, and as new ... market is very much a replacement and upgrade ...
(Date:3/3/2015)... MA (PRWEB) March 03, 2015 The ... transformed the science of the little-known and incurable disease, ... its #CureFSHD campaign . The purpose of the ... FSHD, one of the most common forms of muscular ... off the campaign, today the FSH Society will begin ...
Breaking Medicine News(10 mins):Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 2Health News:Share to be Aware: FSH Society Launches #CureFSHD Campaign 3
... has had a fascinating journey and as they wrap up the ... Blues, it is time for introspection for Bobby Gillespie. The band's ... // ,But after that there was a time when their ... that the "heroin hell" kicked in and it was such a ...
... The exposed super model and ramp queen Kate Moss has ... about getting exposed by the media about her cocaine addiction. // ... Kate Moss is very close to him and he has known ... said to him that it made her face the reality and ...
... from the University of Melbourne and La Trobe University have ... grains such as wheat and barley. With the stress being ... that this discovery would allow them to manipulate the fibre ... the production of beta-glucans, which is a major part of ...
... go on Phase I trial. It maybe as early as ... Shaw. ,Ms.Shaw was speaking at the conference ... for innovation and R&D.// There are close to 34 million ... always bear this in mind and develop products accordingly. ...
... Briton underwent a successful life-changing operation in India and returned ... for being// overweight. ,David Rogers, 62, from Abbeydale, ... overweight for the double hip and knee replacements that he ... he was about 37 kg too heavy for the surgery. ...
... found with breast tumors can predict the outcomes of the ... appearing in he April 1 issue of Clinical Cancer Research, ... risk for an early relapse of breast cancer. ... a potential marker of relapse in hormone-receptor positive breast cancer ...
Cached Medicine News:Health News:Overweight Briton Underwent Successful Surgery In India Being Denied By NHS 2
... series SV stereomicroscopes are of ... to their mature modular design ... job in hand. This is ... demanding routine applications will appreciate, ...
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
10:1 Zoom Ratio - The parallel optical system of the SMZ-1000 has a 10:1 zoom with clickstops at 1X intervals. It features a zoom range of 0.8X to 8.0X and total magnification (depending on eyepieces...
Fixed Versatility - With a diverse selection of body tubes, stands, lighting techniques and Nikon's world-renowned optics, this modular microscope can be configured to fit nearly any application....
Medicine Products: